Liver injury can result from various risk factors including diabetes, virus, alcohol, drugs, and other toxins, which is mainly responsible for global mortality and morbidity. Selenocysteine (Sec), as the main undertaker of selenium function in the life system, features prominently in a series of hepatic injuries and has close association with the pathological progression of liver injuries. Here, we report a mitochondria-targetable lanthanide complex-based probe, Mito-NPTTA-Tb 3+ /Eu 3+ , that can be used for accurately determining Sec in live cells and laboratory animals via the ratiometric time-gated luminescence (TGL) technique. This probe is composed of 2,2':6',2″-terpyridine-Tb 3+ /Eu 3+ mixed complexes as the luminophore, 2,4-dinitrophenyl (DNP) as the responsive moiety and a lipophilic triphenylphosphonium cation (PPh 3+ ) as the mitochondria-targeting moiety. Upon reaction with Sec, accompanied by the cleavage of DNP from the probe molecule, the I 540 / I 690 ratio of the probe increased by 55 times, which enabled Sec to be detected with the ratiometric TGL method. After being incubated with living cells, the probe molecules were selectively accumulated in mitochondria to allow the mitochondrial Sec to be successfully imaged under the ratiometric TGL mode. Importantly, using this probe coupled with the ratiometric TGL imaging technique, the fluctuations of liver Sec in various liver injuries of model mice induced by diabetes, drug, toxin, and alcohol were precisely monitored, revealing that Sec plays an important antioxidant role during the oxidative stress process in liver injury, and the Sec levels have a close interrelationship with the degree of liver injury. All the results suggest that the new probe Mito-NPTTA-Tb 3+ /Eu 3+ could be a potential tool for the accurate diagnosis of liver injury.
Keyphrases
- living cells
- liver injury
- drug induced
- fluorescent probe
- quantum dots
- single molecule
- oxidative stress
- risk factors
- type diabetes
- cell death
- high resolution
- reactive oxygen species
- adverse drug
- sensitive detection
- endoplasmic reticulum
- dna binding
- dna damage
- adipose tissue
- ischemia reperfusion injury
- weight loss
- nitric oxide
- glycemic control
- insulin resistance
- mass spectrometry
- photodynamic therapy
- cardiovascular events
- risk assessment
- hydrogen peroxide